ISSUP hosted a webinar on 4 December 2025 with Dr Sarah Kattakuzhy, exploring integrated care for the syndemic of SUD, HIV, and HCV. She highlighted that these conditions often occur together and intensify one another, making siloed approaches ineffective. The session showcased strong evidence that integrated care models; whether co-located, mobile, telemedicine-supported, or provider-integrated; improve treatment uptake, viral suppression, and HCV cure rates. Case studies illustrated how person-centred, joined-up care strengthens trust, stability, and quality of life. The discussion emphasized the significant opportunity to scale integrated, flexible, and humane care models across diverse health systems.
ISSUP, in collaboration with Faces & Voices of Recovery, has launched a new Global Recovery Network webinar series to spotlight diverse perspectives on recovery. The first webinar featured Dr. Haner Hernández, a respected expert in the field and a person in long-term recovery. Dr. Hernández currently serves as a Senior Consultant to the Massachusetts Department of Public Health and plays a key role in advancing health equity, workforce development, and recovery support. His presentation provided an insightful and inclusive overview of multiple pathways to recovery, grounded in both...
Dal 2015 la Commissione dell'Unione Africana (AUC) organizza una consultazione continentale annuale per la riduzione della domanda di farmaci (DDR). Gli Stati membri dell'AUC sono rappresentati dai rispettivi punti focali nazionali in materia di DDR, offrendo agli Stati membri l'opportunità di presentare le attività nazionali di DDR in una piattaforma di revisione tra pari che consente anche il coinvolgimento di esperti in materia invitati. La consultazione di quest'anno si è tenuta ad Arusha, Tanzania dal 10 al 13 dicembre 2024 e comprendeva i leader tradizionali dell'Africa meridionale...
ISSUP Ucraina è lieta di presentare il secondo webinar della sua serie in tre parti su "Salute mentale dei giovani e sostanza". Il secondo webinar si concentrerà specificamente sui disturbi dell'umore nei bambini e negli adolescenti.
Current evidence shows that medications are underused in the treatment of alcohol use disorder, including alcohol abuse and dependence.
Although many experts in addiction believe that patients with moderate or severe alcohol-related problems should be offered medication-assisted treatment (MAT) on a routine basis, considerable resistance to the use of MAT persists.
To clarify the situation, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) analysed the evidence on the effectiveness of available...
Nelson LF, Yocum VK, Patel KD, Qeadan F, Hsi A, Weitzen S. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(3):e201195. doi:10.1001/jamanetworkopen.2020.1195
Abstract
Importance: The number of children with prenatal opioid exposure to medication for addictiontreatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is increasing, but the associations of this exposure with cognitive outcomes are not well understood.
Objective: To examine the strength and consistency of findings in the medical literature regarding the association of prenatal exposure to MAT with early childhood cognitive development, particularly when accounting for variables outside MAT exposure.
Data Sources: A search strategy obtained publications from...
The Substance Abuse and Mental Health Services Administration (SAMHSA)
The success of treatment and recovery of individuals with opioid use disorder (OUD) can vary. Most often, a combination of factors adds complexities to evaluating the effectiveness of services and interventions.
Worldwide, overdose is the leading cause of avoidable death among people who inject drugs. An important area of concern for the Substance Abuse and Mental Health Services Administration (SAMHSA) is promoting policies and practices to lower the risk of overdose for persons with opioid use disorder who are, or have been, in contact with criminal justice systems.
Moeini, Mina, Abdoallah Omidi, Mojtaba Sehat, and Hamid Reza Banafshe. "The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial." European addiction research 25, no. 1 (2019): 41-48.
According to the World Drug Report opioids are the most harmful drug type, accounting for 70% of the adverse health impacts associated with drug use disorders worldwide. Treatment typically focusses on controlling withdrawal, preventing cravings and ultimately relapse. Maintenance treatments are used for chronic opioid-dependent patients who cannot achieve abstinence.
A recent randomised, double-blind trialhas examined the effectiveness of oxytocin, a neuropeptide that is produced by the hypothalamus, as part of the treatment of addiction. The researchers analysed the effect of oxytocin on...
Drs. Kariisa and Roehler will provide an overview of CDC’s Enhanced State Opioid Overdose Surveillance (ESOOS) program. We will highlight the three key strategies CDC is employing to improve opioid-related...